#42 - Nicole K. Paulk, CEO & Founder at Siren Biotechnology
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guest: Nicole K. Paulk, CEO & Founder at Siren Biotechnology.
What you'll get out of this episode:
- Nicole Paulk's early inspiration in gene therapy during her PhD at OHSU.
- The transition from academia to entrepreneurship amid COVID-19.
- Siren Biotechnology's innovative approach with AAV immunogene therapy.
- The challenges and successes in securing funding and navigating regulatory landscapes.
- The exciting transition of Siren Biotechnology from preclinical to clinical trials.
To Learn More About Our Guest And Their Company:
LinkedIn https://www.linkedin.com/in/nicolepaulk/
Company LinkedIn https://www.linkedin.com/company/siren-biotechnology-inc/
Website https://sirenbiotechnology.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/